tbuckley/cabot-search huggingface dataset:
The Medical Directory of the City of New York.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Increased Prevalence of Autoimmune Phenomena and Greater Risk for Alloreactivity in Female Heart Transplant Recipients
Authors: Katherine Lietz, Ranjit John, Alfred Kocher, Michael Schuster, Donna M. Mancini, Niloo M. Edwards, Silviu Itescu
Journal: Circulation (2001)

Background The influence of sex on alloreactivity and graft outcome after heart transplantation was evaluated. Methods and Results A retrospective review of 520 consecutive recipients of a primary cardiac allograft between 1992 and 2000 at a single center was performed. The influence of sex on alloreactivity, acute rejection, transplant-related coronary artery disease, and survival was determined. Statistical methods included logistic regression analysis and Kaplan-Meier actuarial survival analysis. Female recipients had an increased prevalence before transplant of idiopathic cardiomyopathy, antinuclear antibodies, and HLA-B8, DR3 haplotypes. After transplant, female sex predicted shorter duration to a first rejection, higher cumulative rejection frequency, and earlier posttransplant production of anti-HLA antibodies. Female recipients had higher early mortality rates (&lt;6 months) that were due to infection. Fatal infections correlated with 2-fold higher cyclosporine levels in female recipients. However, the incidence of transplant-related coronary artery disease developing beyond 1 year after transplant was lower in female than in male recipients. Conclusions Females undergoing cardiac transplantation are more likely to manifest features of an underlying autoimmune state. This may predispose to a higher posttransplant risk of allograft rejection and requirement for increased immunosuppression. Earlier diagnosis and management of alloreactivity in female recipients before development of acute rejection and the use of more focused and less globally immunosuppressive agents during established rejections may have a significant effect on the clinical outcome of female cardiac allograft recipients.
Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma
Authors: D. R. Sorensen
Journal: Neuro-Oncology (2002)

Endostatin, the 20-kDa C-terminal fragment of collagen XVIII, has previously been shown to inhibit growth and induce regression of different experimental tumors in rodents.In this study, we show that recombinant murine and human endostatin, produced in 293 EBNA cells and yeast, respectively, inhibit ectotopic as well as orthotopic growing BT 4 C n gliosarcomas in BD-IX rats.In rats in which s.c.gliomas were grown for a total of 29 days, systemic treatment with recombinant murine endostatin induced about 50% reduction of intratumoral blood ow and tumor size after only 10 days of therapy.In contrast, the blood ow to irrelevant organs was unaffected by endostatin, indicating its speci city of action.Tumors were not observed to increase in size or regrow after cessation of therapy.Furthermore, endostatin-treated rats with i.c.tumors had signi cantly longer survival time than did untreated controls.In the treated rats, endostatin therapy resulted in a reduced tumor blood vessel volume and an increased tumor cell density with an increased apoptotic index within a given tumor volume, as veri ed by ow cytometry and by staining with deoxynucleotidyltransferase-mediated dUTP nick-end labeling.This work veri es the general anti-angiogenic and antitumor effects of endostatin and indicates that the protein may also be considered as a treatment strategy for malignant brain tumors.
Highlights From the <i>Circulation</i> Family of Journals
Authors: Thomas Lynge, Alexander Jeppesen, Bo Gregers Winkel, Charlotte Glinge, Michael Schmidt, Lars Søndergaard, Bjarke Risgaard, Jacob Tfelt-Hansen, Cheryl Winker, Jeffrey Kopp, Orlando Gutiérrez, Marguerite Irvin, Ninad Chaudhary, Mary Cushman, Neil Zakai, Victor David, Sophie Limou, Nathalie Pamir, Alex Reiner, Rakhi Naik, Michele Sale, Monika Safford, Hyacinth Hyacinth, Suzanne Judd, Cheryl Winkler, Adriaan Coenen, Young-Hak Kim, Mariusz Kruk, Christian Tesche, Jakob De Geer, Akira Kurata, Marisa Lubbers, Joost Daemen, Lucian Itu, Saikiran Rapaka, Puneet Sharma, Chris Schwemmer, Anders Persson, U Schoepf, Cezary Kepka, Dong Yang, Koen Nieman, Emanuele Barbato, Stephane Fournier, Gabor Toth, Bernard De Bruyne, Nils Johnson, Giovanni Ciccarelli, Panagiotis Xaplanteris, Anastasios Milkas, Teresa Strisciuglio, Jozef Bartunek, Marc Vanderheyden, Eric Wyffels, Filip Casselman, Frank Praet, Bernard Stockman, Ivan Degrieck, Heli Virtanen, Sari Voutilainen, Timo Koskinen, Jaakko Mursu, Tomi-Pekka Tuomainen, Jyrki Virtanen
Journal: Circulation (2018)

This nationwide Danish study investigated the incidence of sudden cardiac death in young people with congenital heart defects.The authors found that the incidence of sudden cardiac death-congenital heart defects in infants declined after the implementation of nationwide fetal ultrasound screening, the proportion of sudden cardiac death-congenital heart defects in the young was higher than previously reported, and the incidence rate of sudden cardiac death during physical activity among young people with congenital heart defects was low.
Errors in Reported Data
Journal: JAMA Dermatology (2017)

Vassiliki Tzanetakou, MD; Theodora Kanni, MD; Sophia Giatrakou, MD; Alexandros Katoulis, MD, PhD; Evangelia Papadavid, MD, PhD; Mihai G. Netea, MD, PhD; Charles A. Dinarello, MD, PhD; Jos W. M. van der Meer, MD, PhD; Dimitrios Rigopoulos, MD, PhD; Evangelos J. Giamarellos-Bourboulis, MD, PhD
Association Between Youth-Focused Firearm Laws and Youth Suicides—Correction
Authors: Davey Smith, Joseph Wong, George Hightower, Caroline Ignacio, Kersten Koelsch, Eric Daar, Douglas Richman, Susan Little
Journal: JAMA (2004)

should thus continue vigilant personal protection through safe-sex practices or clean needle use for injection drugs, even if their risk exposures are with other HIV-infected people.
Comparative Study of Three Respiratory Stimulants in Chronic Obstructive Emphysema
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Instructions for Authors
Journal: JAMA (1979)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Galactorrhoea
Authors: A. E. Dormer, R. W. E. Watts
Journal: BMJ (1962)

OTITIS EXTERNA MBIrIrS 609 should require the minimum number of attendances; in addition the cost should not be high.The combination of framycetin, gramicidin, and dexamethasone meets these requirements.The concept of otomycosis as a commonly occurring disease has been examined.Further evidence must be awaited before conclusions can be drawn, but the weight of evidence is not at the moment in its favour.My thanks are due to Dr.
Proceedings of the British Thoracic Society
Authors: D Pitson, A Van Baardwijk, J Cleven, Rjo Davies, Jrs Stradling, P Nolan, J O'donnell, R O'regan, W Mcnicholas, C Power, C Burke, S Sreenan, L Poulter, Pfg Gannon, D Newton, B Higgins, H Francis, C Warburton, C Yates, A Fletcher, Cac Pickering, A Woodcock, Wythenshawe Hospital, J Moran, J Green
Journal: Thorax (1993)

Osler Chest Unit, Churchill Hospital, Oxford Daytime sleepiness and impaired vigilance are features of obstructive sleep apnoea (OSA) and there is growing evidence to link snoring with daytime sleepiness even in the absence of OSA.The performance of 183 patients with OSA, obstructive sleep hypopnoea, or snoring was compared with 39 asymptomatic community controls on a multiple unprepared reaction time test.Oxygen saturation dip rate (number >4% Sao2 dips per hour) was used to divide the patients into two groups: those with five or fewer dips of >4%/hour (n = 96), and those with more than five dips of >4%/hour (n = 87).The figure below shows the 95th centile for reaction times during the second half of the test (ms) for each group.Analysis of variance and Duncan's multiple range test showed that both patient groups differed significantly from the controls (p = 0 01) but that there was no significant differ- ence between the two patient groups.Thus patients who snore but do not have a significant number of dips in oxygen saturation have impaired vigilance compared with normal subjects and similar vigilance to those with classical OSA.This deficit is similar to that pro- duced by one night of sleep deprivation.This has important implications for the use of oximetry alone as a screening tool for sleep related breathing disorders.A low dip rate cannot rule out sympto- matic snoring related sleep disruption.95th centile for reaction times (2nd half of test)in the three groups of subjects
Anna Karenina
Authors: Leo Tolstoy
Journal: Annals of Internal Medicine (1998)

Brief Communications15 April 1998Anna KareninaLeo TolstoyLeo TolstoySearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-8-199804150-00008 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail And the doctor gave the princess, as though she were an exceptionally intelligent woman, a scientific diagnosis of the young princess's condition, concluding with directions for taking the useless waters. At the question as to whether they should go abroad, the doctor began pondering profoundly, as though solving a difficult problem. The answer was finally given: they were to go abroad, and not believe what the quacks told them, but refer to him about everything.Leo TolstoyAnna KareninaSubmitted by: Dean H. Gesme Jr., MD; Cedar Rapids, IA 52403Submissions from readers are welcomed. If the quotation is published, ... Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byEmergence and Experience of “Peace of Mind”: What Can Classic Writers Tell Us?Positron Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tool for Developing Novel Pharmacotherapeutics for Obesity and DiabetesL’aspectualité des constructions verbo-nominales de sentiment en français et en russeNumerical analysis of strongly nonlinear PDEsPositron-Emission Tomography and Computed Tomography Measurement of Brown Fat Thermal Activation: Key Tools for Developing Novel Pharmacotherapeutics for Obesity and DiabetesFictional Objects: How they are and how they aren’t 15 April 1998Volume 128, Issue 8Page: 656KeywordsProblem solving Issue Published: 15 April 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Book Reviews
Authors: Harold L. Levitan, Finn Askevold, Carl Fellner, Charles D. Kaplan, Michael Wogan, F. Berger, R. Rauskolb, M. Schütz, S. Stephanos, W.W. van der Schaar, Hoyle Leigh, James Ungerer, Adrian Ostfeld, Robert Drake, Morton F. Reiser, D. Beckmann, F. Berger, G. Leister, S. Stephanos, Harley C. Shands, Miguel A. Leibovich, Murray Cox, Caroline Cox, Rolf Adler, Jürg M. Herrmann, Nikolaus Schäfer, Thomas Schmidt, Othmar W. Schonecke, Thure v. von Uexküll, Stephen H. Armstrong, Mitchell Hendrix, C. Maggini, M. Guazzelli, P. Castrogiovanni, M. Mauri, G.F. de Lisio, S. Chierchia, G.B. Cassano
Journal: Psychotherapy and Psychosomatics (1976)
A RUSSIAN LIBEL ON PHYSICIANS.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Dosage
Journal: JAMA (1982)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
Authors: Robert Zeiser, Nicola Polverelli, Ron Ram, Shahrukh K. Hashmi, Ronjon Chakraverty, Jan Moritz Middeke, Maurizio Musso, Sebastian Giebel, Ant Uzay, Peter Langmuir, Norbert Hollaender, Maanasa Gowda, Tommaso Stefanelli, Stephanie J. Lee, Takanori Teshima, Franco Locatelli
Journal: New England Journal of Medicine (2021)

Chronic graft-versus-host disease (GVHD), a major complication of allogeneic stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent in approximately 50% of patients. Robust data from phase 3 randomized studies evaluating second-line therapy for chronic GVHD are lacking. In retrospective surveys, ruxolitinib, a Janus kinase (JAK1–JAK2) inhibitor, showed potential efficacy in patients with glucocorticoid-refractory or -dependent chronic GVHD.
Medical Education—Preload and Afterload
Authors: Samuel Vaisrub
Journal: JAMA (1978)

While the physician scans undecidedly the various continuing medical education (CME) programs for category 1 accreditation, his son or daughter may be similarly unsure about course selection for premedical studies. He or she, however, is sure of one decision—the major course will be a science. They believe that science is more relevant to their career, and they know that in the Medical College Admissions Test, the science part wields more clout. Should they decide to take a minor course in the humanities, they are likely to choose one that requires the least time and effort. If ever support was needed for C. P. Snow's tenuous two-cultures thesis, the science bias of the premedical studies provides one. Ironically, it does it now when, more than ever, medicine demands from the physician the broadest possible intellectual scope to meet the complexities of the times. In a recent "Notes of a Biology-Watcher," Lewis
Cognitive Behavior Therapy for Older Patients With Generalized Anxiety Disorder—Reply
Authors: Melinda A. Stanley
Journal: JAMA (2009)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Society Proceedings
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Use of over-the-counter nicotine patch for smoking cessation: prudent or premature?
Authors: S. E. McNagny
Journal: JAMA (1996)

<h3>To the Editor.</h3> —In a well-designed and thoughtful analysis, Drs Fiscella and Franks<sup>1</sup>determine the incremental costeffectiveness of the transdermal nicotine patch for smoking cessation as an adjunct to physician counseling. The authors conclude that their findings support both the use of the nicotine patch and health insurance coverage of patch therapy. We heartily endorse these conclusions. The authors also conclude that their analysis does not support over-the-counter (OTC) use of the patch since their model was insensitive to incremental changes in physician time. We respectfully question this conclusion. The only costs considered in the authors' analysis, those of patch and physician counseling, would be nil with OTC use for anyone obtaining patches without physician counseling. Thus, from the perspective of the medical payer used in their model, patch use would become highly costeffective, even if patch effectiveness were found to be significantly lower with OTC use. The key
Examinations for Oral Cancer—United States, 1992
Journal: JAMA (1994)

During 1992, oral cancer (i.e., cancers of the oral cavity and pharynx) was diagnosed in approximately 30,000 persons in the United States and caused nearly 8000 deaths (1); approximately 70% of deaths from oral cancer are associated with smoking (2) and other forms of tobacco use (3). Although the 5-year survival rate (53%) for persons with oral cancer remains low, survival varies by stage at diagnosis (4). Detection of oral cancers by oral examination can reduce morbidity and death associated with this problem (5). To characterize examinations for oral cancer among U.S. adults, CDC analyzed data from the 1992 National Health Interview Survey-Cancer Control (NHIS-CC) supplement. This report summarizes findings from that analysis.